Metabolic therapy effects on cardioversion results in persistent atrial fibrillation

Metabolic therapy effects on cardioversion results in persistent atrial fibrillation

.

Bibliographic Details
Main Authors:	A. A. Kotlyarov, T. S. Aleksandrova, A. N. Gribanov, T. N. Karyakina
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2008-06-01
Series:	Российский кардиологический журнал
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/1569

Similar Items

Defining the benefit: Cardioversion of persistent atrial fibrillation
by: Sotirios Nedios, et al.
Published: (2021-10-01)

PAROXYSMAL ATRIAL FIBRILLATION: CHOICE OF CARDIOVERSION THERAPY
by: B. A. Tatarskii
Published: (2015-12-01)

PAROXYSMAL ATRIAL FIBRILLATION: CHOICE OF CARDIOVERSION THERAPY
by: B. A. Tatarskii
Published: (2015-12-01)

Rivaroxaban in atrial fibrillation cardioversion: an update
by: Lavalle C, et al.
Published: (2019-05-01)

Safety and Effectiveness of Electrical and Pharmacological Cardioversion in Persistent Atrial Fibrillation. Part 2: Assessment of Safety
by: N. Yu. Mironov, et al.
Published: (2019-01-01)

Cardioversion for atrial fibrillation during pregnancy
by: Dodji Kossi Djakpo, et al.
Published: (2019-06-01)

Pharmacological cardioversion for atrial fibrillation and flutter
by: Cordina J, et al.
Published: (2006-01-01)

Atrial fibrillation : prediction of successful cardioversion
by: Runnett, Craig
Published: (2007)

Ogilvie’s Syndrome following Cardioversion for Atrial Fibrillation
by: Moh’d Al-Halawani, et al.
Published: (2014-01-01)

CARDIOVERSION WITH BI- AND MONOPHASE DEFIBRILLATORS IN PATIENTS WITH PAROXYSMAL ATRIAL FIBRILLATION
by: V. A. Lusov, et al.
Published: (2010-02-01)

Refralon (niferidil) is a new class III antiarrhythmic agent for pharmacological cardioversion for persistent atrial fibrillation and atrial flutter
by: E B Maĭkov, et al.
Published: (2015-01-01)

Electrical Cardioversion in Atrial Fibrillation: Success Rates
by: JRMC Admin, et al.
Published: (2018-09-01)

Predictors of success of electrical cardioversion for atrial fibrillation
by: Marleny Cruz Cardentey, et al.
Published: (2016-07-01)

Current Status of Internal Cardioversion in Atrial Fibrillation.
by: Andreas Plewan, et al.
Published: (2002-04-01)

THE IMPORTANCE OF EARLY CARDIOVERSION OF PAROXYSMAL ATRIAL FIBRILLATION
by: Franc Verovnik
Published: (2002-01-01)

Waveform optimisation for internal cardioversion of atrial fibrillation
by: Kodoth, Vivek Nambiar
Published: (2012)

Cardioversion of atrial fibrillation : a novel approach
by: Manoharan, G.
Published: (2001)

Efficacy and Safety of Bepridil for Patients with Persistent Atrial Fibrillation after Failed Electrical Cardioversion
by: Yasuyuki Egami, MD, et al.
Published: (2011-01-01)

Prognosis following external electrical cardioversion for persistent atrial fibrillation : electrocardiographic risk assessment
by: Guo, Xiao Hua
Published: (2004)

Dabigatran Etexilate in the course of Electrical Cardioversion in Patients with Non-Valvular Atrial Fibrillation
by: N. A. Novikova, et al.
Published: (2016-11-01)

Safety and Effectiveness of Electrical and Pharmacological Cardioversion in Persistent Atrial Fibrillation. Part I: Study Rationale, Design and Assessment of Effectiveness
by: N. Yu. Mironov, et al.
Published: (2018-11-01)

Predicting of Long-term Maintenance of Sinus Rhythm after Cardioversion in Patients with Nonvalvular Persistent Atrial Fibrillation
by: Zharinov O., et al.
Published: (2014-12-01)

Atrial mechanical hypofunction after electrical cardioversion of persistent or long-lasting persistent atrial fibrillation: a retrospective cohort study
by: Renato De Vecchis, et al.
Published: (2019-12-01)

Pharmacological Cardioversion after Pre-Treatment with Antiarrythmic Drugs Prior to Electrical Cardioversion in Persistent Atrial Fibrillation: Impact on Maintenance of Sinus Rhythm
by: Amine El Amrani, et al.
Published: (2021-03-01)

Prediction of sinus rhythm maintenance following DC-cardioversion of persistent atrial fibrillation – the role of atrial cycle length
by: Carlson Jonas, et al.
Published: (2006-03-01)

Utilization and Predictors of Electrical Cardioversion in Patients Hospitalized for Atrial Fibrillation
by: Yogita M. Rochlani, et al.
Published: (2016-01-01)

External electrical cardioversion of persistent atrial fibrillation in a patient with a Micra™ Transcatheter Pacing System
by: K. Filipovic, et al.
Published: (2018-01-01)

Pretreatment with ACE inhibitors improves acute outcome of electrical cardioversion in patients with persistent atrial fibrillation
by: Van Veldhuisen Dirk J, et al.
Published: (2005-01-01)

The clinical condition and functional performance of the heart in patients with persistent atrial fibrillation after electrical cardioversion.
by: K. А. Pysarevska
Published: (2016-03-01)

The clinical condition and functional performance of the heart in patients with persistent atrial fibrillation after electrical cardioversion
by: Pysarevska K.О.
Published: (2016-03-01)

Electric cardioversion as therapeutic modality in patients with atrial fibrillation
by: Raúl Joaquín Varela García
Published: (2018-08-01)

Transvenous, intracardial cardioversion for the treatment of postoperative atrial fibrillation
by: Fitzgerald Robert, et al.
Published: (2008-01-01)

The Role of Biphasic Shocks for Transthoracic Cardioversion of Atrial Fibrillation
by: Simon J Walsh, et al.
Published: (2005-10-01)

Initial Energy for External Electrical Cardioversion of Atrial Fibrillation
by: Edilberto Figueiredo, et al.
Published: (2002-08-01)

Cardioversion of atrial fibrillation does not affect obstructive sleep apnea
by: Niklas Höglund, et al.
Published: (2017-04-01)

Left atrial appendage thrombosis during therapy with rivaroxaban in elective cardioversion for permanent atrial fibrillation
by: Walter Serra, et al.
Published: (2015-09-01)

Left atrial emptying fraction determined during atrial fibrillation predicts maintenance of sinus rhythm after direct current cardioversion in patients with persistent atrial fibrillation.
by: Paweł Wałek, et al.
Published: (2020-01-01)

Anticoagulation in Atrial Fibrillation Cardioversion: What Is Crucial to Take into Account
by: Fabiana Lucà, et al.
Published: (2021-07-01)

Safety and efficacy of vernakalant for acute cardioversion of atrial fibrillation: an update
by: Dobrev D, et al.
Published: (2013-04-01)

Clinical experience of dabigatran and rivaroxaban in electrical cardioversion of atrial fibrillation
by: Charlène Coquard, et al.
Published: (2015-01-01)